This chapter of the podcast delves into the role of pharmacy benefit managers (PBMs) in the healthcare system, discussing their negotiation of lower prices, the scrutiny they face, and the ongoing debate about rebates in the pharmaceutical industry. It also explores the consolidation of the PBM market and the influence these companies have over drug availability. The chapter highlights the financial ties of actors in the pharmaceutical industry to a drug's list price and the bipartisan interest in regulating this space.
Bloomberg Intelligence Senior Retail Analyst Mary Ross Gilbert and Bloomberg News Reporter Simone Foxman discuss Macy’s, Lowe's and Dick’s earnings. Bloomberg News US Semiconductor & Networking Reporter Ian King has a preview of Nvidia earnings. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Health Care Reporter John Tozzi provide the details of John's Businessweek Magazine story Drug Benefit Firms Devise New Fees That Go to Them, Not Clients. And we Drive to the Close with Lauren Sanfilippo, Senior Investment Strategy Analyst for the Chief Investment Office at Bank of America Corporation.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.